The Department of Psychiatry's annual Schizophrenia Education Day presents new research findings and important clinical topics for patients with schizophrenia and their families. Clinicians share their vision of modern psychiatric treatment that is preventive, patient-centered and oriented toward recovery and physical health.
No Health Without Planetary Health: Climate Change and Mental Illness
Oliver Freudenreich, MD, FACLP
Neighborhoods and Mental Health: Effects on Psychosis Risk
Teresa Vargas, PhD
Criminal Legal Involvement for People with Serious Mental Illness
Faith Scanlon, PhD
Current Challenges in Child and Adolescent Mental Health
Abigail Donovan, MD
Schizophrenia care – 20 years of progress
Oliver Freudenreich, MD, FACLP
Research on the neural basis of schizophrenia “then” and “now”
Daphne J. Holt, MD, PhD
MGH Psychosis Clinical and Research Program: stage-based care for schizophrenia
Abigail Donovan, MD
Therapy for people recovering from psychosis: harnessing its promise
Cori Cather, PhD
Welcome
Daphne J. Holt, MD, PhD
Serious Mental Illness During a Pandemic
Oliver Freudenreich, MD, FACLP
The Impact of COVID-19 on Persons With Lived Experience
Abigail Wright, PhD
Resilience During COVID-19
Daphne J. Holt, MD, PhD
Patient and Clinician Experiences During COVID-19
Cori Cather, PhD
The impact of COVID-19 on young people and pathways to recovery
Nicole DrTore, PhD
Community Psychiatry Progress and Challenges - Oliver Freudenreich, MD, FACLP, co-director of the Schizophrenia Clinical and Research Program
Should I go to the gym today? Exercise as a Valuable Part of Recovery and Well-Being - Julia Browne, PhD, a clinical and research fellow in the Center of Excellence for Psychosocial and Systemic Research
Early Detection of Psychosis in your Neighborhood, School and Doctor’s Office, What Will It Take - Daphne J. Holt, MD, PhD, co-director of the Schizophrenia Clinical and Research Program, director of the Emotion and Social Neuroscience Laboratory and specialist in the Resilience Program.
Priorities and Needs of Individuals Affiliated with Recovery Communities Across Massachusetts - certified peer specialists Jacqueline Martinez, Sandra Whitney-Sarles and Anne Whitman
The Center of Excellence for Psychosocial and Systemic Research: Who are we, what have we done and where are we going? - Cori Cather, PhD, a clinician-researcher with training in behavioral medicine and cognitive behavioral therapy
2018: Progress in Schizophrenia: New Insights into Brain Development - Topics include development of new drugs and technology for treating schizophrenia and how early brain development may be related to development of schizophrenia.
2017: “Outside the Box" in Psychosis Treatment - Towards stage-based & symptom-targeted interventions. Topics include risk and resilience in vulnerable youth, early intervention for first episode psychosis, and the new treatment options.
Use of Information Technology in Schizophrenia - Hannah Brown, MD, director of research for the First Episode and Early Psychosis Program
Update on Early Brain Development and Risk for Schizophrenia - Joshua Roffman, MD, MMSc, director of research for the Schizophrenia Clinical and Research Program
Cannabis Update for Patients with Schizophrenia - A. Eden Evins, MD, MPH, director of the Center for Addiction Medicine
New Drug Development for Schizophrenia - Oliver Freudenreich, MD, FACLP, co-director of the Schizophrenia Clinical and Research Program
Risk & Resilience: Tipping the Balance in Vulnerable Youth - Daphne J. Holt, MD, PhD
Intervening Early & Well with a First Episode of Psychosis - Yoshio Kaneko, MD
Autism Spectrum Disorder & Schizophrenia: Shared Traits & Treatment - Drew C. Coman, PhD
Transcranial Magnetic Stimulation: A New Treatment Approach for Psychiatric Disorders - Tracy Barbour, MD
November 5, 2016
The 14th Annual Schizophrenia Education Day presented new research findings and important clinical topics for patients with schizophrenia and their families. Clinicians shared their vision of modern psychiatric treatment that is preventive, patient-centered and oriented towards recovery and physical health.
Watch archived presentations from the event.
Open dialogue: A family-based approach to care for early-episode psychosis - Chris Gordon, MD
Is it shyness or lack of interest? Using neuroscience to understand negative symptoms - Daphne J. Holt, MD, PhD
A mentalization-based approach to social deficits in schizophrenia - Benjamin K. Brent, MD, MS
What new studies of adolescent brain development are telling us about schizophrenia - Joshua L. Roffman, MD
This program is made possible by anonymous donors who have given generously to support this program.
The Psychosis of Everyday Life: Implications for Early Detection and Prevention - Daphne J. Holt, MD, PhD
Improving cancer outcomes for individuals with schizophrenia - Kelly Irwin, MD
Becoming Your Own Best Resource: Lessons from the Illness Management and Recovery Curriculum - Adrienne T. Gerken, MD
New Treatments for Schizophrenia - Oliver Freudenreich, MD, FAPM
These videos are provided with generous funding from the National Alliance on Mental Illness (NAMI) Cambridge/Middlesex.
12th Annual Schizophrenia Education Day presented by the Department of Psychiatry at Massachusetts General Hospital.
Why Do We Sleep? The Critical Role of Sleep in Learning and Memory
Dara Manoach, PhD
Drilling Down to Bedrock: An Update on the Genetics of Schizophrenia
Joshua Roffman, MD, MMSc
Health Recovery: A Holistic Approach to Care
Sarah MacLaurin, APRN
My Voices Ate My Homework: Schizophrenia in the Developing Adolescent
John Tyson, MD
Important new clues about the genetic basis of schizophrenia have emerged in a landmark study led by investigators at the Analytic and Translational Genetics Unit (ATGU) at MGH and the Broad Institute of MIT and Harvard.
A study in mice may provide new insights into human interactions and advance research related to autism spectrum disorder and other neurocognitive conditions.
Men and women whose mothers experienced stressful events during pregnancy regulate stress differently in the brain 45 years later, results of a long-term study demonstrate.
Psychiatric researchers have identified interactions between genes and sex that might partly explain how major psychiatric disorders affect males and females differently. The findings could spur better treatments for major psychiatric disorders.
In the largest-ever study of its kind researchers identified more than 100 genetic variants that affect the risk for more than one mental health condition.
The First-episode and Early Psychosis Program (FEPP) evaluates and treats people in the critical early stages of schizophrenia or related psychotic illnesses.
The Department of Psychiatry provides resources for patients and families including educational programs and information about mental health issues.
